US President Donald Trump's administration has secured almost all the world's upcoming supply of the drug remdesivir.
The drug, produced by the firm Gilead Sciences, is the first approved by authorities in the US to be used to treat Covid-19.
It has been shown to help people recover faster from the disease.
A statement from the Department of Health and Human services says Trump struck an "amazing" deal with Gilead for 500,000 doses which amounts to 100% of Gilead's production in July, 90% of it in August and 90% in September.
A treatment course of remdesivir is, on average, 6.25 vials.
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Latest Stories
-
Expansion Drive: Takoradi Technical University increases faculties
45 minutes -
SHS heads demand payment of outstanding funds before reopening of schools
1 hour -
We thank God for the 2024 general elections – Akufo-Addo
2 hours -
Coconut Grove Beach Resort marks 30 years of excellence with memorable 9 lessons & carols service
2 hours -
WAFU B U-17 Girls’ Cup: Black Maidens beat Nigeria on penalties to win inaugral tournament
3 hours -
Real Madrid beat Sevilla to keep pressure on leaders Atletico
4 hours -
Liverpool put six past Spurs to go four points clear
4 hours -
Manchester United lose 3-0 at home to Bournemouth yet again
4 hours -
CHAN 2024Q: ‘It’s still an open game’ – Didi on Ghana’s draw with Nigeria
4 hours -
CHAN 2024Q: Ghana’s Black Galaxies held by Nigeria in first-leg tie
5 hours -
Dr Nduom hopeful defunct GN bank will be restored under Mahama administration
5 hours -
Bridget Bonnie celebrates NDC Victory, champions hope for women and youth
5 hours -
Shamima Muslim urges youth to lead Ghana’s renewal at 18Plus4NDC anniversary
6 hours -
Akufo-Addo condemns post-election violence, blames NDC
7 hours -
DAMC, Free Food Company, to distribute 10,000 packs of food to street kids
8 hours